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TO THE EDITOR
Woolly hair nevus (WHN) is a mosaic
disorder characterized by distinct pat-
terns of tightly curled scalp hair, which
can appear concurrently with epidermal
nevi (EN) at other sites (Peteiro et al.,
1989; Venugopal et al., 2012). Woolly
hair is also found in congenital disorders
resulting from mutations affecting diverse
cellular components, including
intermediate filament, adherens junction,
and signal–transduction proteins (Harel
and Christiano, 2012).
Embryonic somatic mutation causes
mosaic disorders, which appear in pat-
terns of ectodermal progenitor dorso-
vental migration. Somatic mutations
causing mosaic disorders, including
Proteus syndrome (Lindhurst et al.,
2011), port-wine stains (Shirley et al.,
2013), and EN (Levinsohn et al., 2013;
Sun et al., 2013), have been found using
exome sequencing.
Recognizing that exome sequencing
would permit identification of mutations
causing WHN, we ascertained two
cases. Our first (WHN100; Figure 1a–d)
case was a 10-year-old girl without
history of developmental delay who
had regions of slightly curly hair over
her occipital scalp from infancy, which
progressively curled with no scalp sur-
face change and lie alongside the areas
of straight hair. She had hyperpigmented
patches on her neck, trunk, and arms,
with more keratotic lesions on her
distal extremities, and acanthosis nigri-
cans in both axillae. There was linear
palmoplantar keratoderma (PPK) and
hyperkeratosis over most metacarpopha-
langeal and some proximal interphalan-
geal joints. Given concurrent PPK and
woolly hair, clinical concern for Naxos
or Carvajal syndromes led to regular
cardiology evaluations that found no
abnormalities.
Our second case (WHN101;
Figure 1e–h) was a 6-year-old girl whose
hair developed at age 1 and consisted of
a mixture of poker-straight hair and
curly, thin hair. In infancy, she devel-
oped linear dyspigmentation on the
right arm and trunk, which became
more raised and scaly on the distal
extremities over time. She had normal
development, with no cardiac or oph-
thalmic abnormalities found on routine
physical examination, cardiac mag-
netic resonance imaging, and serialAccepted article preview online 15 October 2013; published online 14 November 2013
Abbreviations: CS, Costello syndrome; KEN, keratinocytic epidermal nevus; LOH, loss of heterozygosity;
NS, nevus sebaceus; PPK, palmoplantar keratoderma; SNV, single nucleotide variation; WHN, woolly hair
nevus
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electrocardiograms. Clinical suspicion
of mosaic Naxos or Caravajal syndrome
motivated clinical sequencing of DSP,
DSC1, DSG1, JUP, PKP2, and TMEM43;
no mutations were found.
To determine the genetic basis of
WHN, we performed paired whole-
exome sequencing of DNA isolated
from affected tissue and blood in both
cases (Supplementary Table S1 online).
Data were analyzed to identify somatic
single nucleotide variants (SNVs), dele-
tions, and insertions (Supplementary
Methods online). A somatic heterozy-
gous HRAS c.34G4A, p.G12S substitu-
tion was found in each (Figure 2a).
There was no evidence of loss of hetero-
zygosity (LOH) (Supplementary Figure
S1 online) or secondary mutation
somatic mutation, suggesting that HRAS
mutation alone is sufficient to cause
WHN. Sanger sequencing confirmed
mutation presence in affected tissue
(Figure 2b and c). To determine whether
this mutation causes woolly hair, we
prepared DNA from hair bulbs of
straight and curly hair obtained from
affected individual WHN101, finding
the HRAS p.G12S mutation in curly hair
only (Figure 2d and Supplementary
Figure S2 online).
Consistent with somatic mosaicism in
an epidermal progenitor, prior cases of
WHN have been reported with concur-
rent keratinocytic epidermal nevi (KEN).
KEN result from somatic mutations in
HRAS, KRAS, PIK3CA, FGFR3, and
NRAS (Hafner et al., 2012) including
the HRAS p.G12S mutation found in
WHN (Hafner et al., 2011). Further-
more, Costello syndrome (CS), in
which patients present with develop-
mental delay, high birth weight,
feeding difficulties, failure to thrive,
cardiac anomalies, and curly hair,
results from germline heterozygous
HRAS mutations, including p.G12S
(Gripp and Lin, 2012; Siegel et al.,
2012). The timing of somatic mutation
during embryonic development deter-
mines extent of cutaneous involvement
and presence of other systemic
abnormalities (Moss et al., 1993).
Notably, somatic activating HRAS
mutations are found in most cases of
nevus sebaceus (NS), a mosaic lesion
which typically appears on the scalp
and features alopecia, papillomatosis,
and marked sebaceous hyperplasia
(Groesser et al., 2012; Levinsohn et al.,
2013; Sun et al., 2013). These features
contrast with those of WHN in which
hair is present but curly, and sebaceous
hyperplasia is absent. Given that WHN
and NS are both caused by somatic
HRAS mutations, we hypothesize that
*
*
*
Figure 1. Clinical features of index cases with woolly hair nevi (WHN). On the scalp, woolly hair nevus presents with a portion of the scalp exhibiting patches of
curly thin hair intermixed with regions of normal, straight hair, as observed in WHN100 and WHN101. On the body, additional findings of linear palmoplantar
keratoderma (b, f, asterisks) and epidermal nevi (c, g) are found. In WHN100, histology of linear palmoplantar keratoderma (d) shows papillomatosis,
hypergranulosis, and compact hyperkeratosis. Bar¼0.5mm. In the epidermal nevus of WHN101, histology of the epidermal nevus (h) shows acanthosis,
papillomatosis, and mild hyperkeratosis. Bar¼ 0.25 mm.
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their phenotypic divergence may derive
from relative potency of the mutant
allele with respect to mitogen-activated
protein kinase activation. HRAS muta-
tions in WHN and NS fall within
the finger loop of HRAS, replacing
glycine residues with larger amino
acids that prevent guanosine triphos-
phate hydrolysis (Malumbres and
Barbacid, 2003). Though comparison
of the WHN p.G12S mutation and the
common NS p.G13R mutation has not
been performed, HRAS codon 12 serine
substitutions have been shown to be less
activating than arginine, aspartic acid,
or valine substitutions (Fasano et al.,
1984).
To evaluate the frequency of HRAS
mutation in NS, we screened 116
archival scalp NS lesions for HRAS
and KRAS mutations. We found 88
HRAS and 9 KRAS mutations. HRAS
p.G13R was present in 85 NS and
p.G12S was not found (Supplementary
Table S2 online). In prior reports, 64
additional samples were screened, and
HRAS p.G12S mutations were not found
(Levinsohn et al., 2013; Sun et al.,
2013). In one report, three specimens
with HRAS p.G12S mutations were
identified; in two there was a con-
current HRAS p.G13R mutation, and in
one, the lesion was on the ear, a site at
which it could be difficult to distinguish
EN and NS (Groesser et al., 2012).
These data combined with evidence
from CS suggest that more strongly
activating RAS mutations may cause
the alopecia and sebaceous hyperp-
lasia found in NS, and the more mildly
activating p.G12S mutation causes
woolly hair phenotypes.
In summary, we find somatic HRAS
c.34G4A, p.G12S mutation in affected
tissue from two cases with mosaic
woolly hair and EN. Consistent
with reports of WHN and in KEN, the
identified p.G12S mutation causes an
EN phenotype on the body, but the
finding of curly hair on the scalp sug-
gests that WHN represents a mosaic
RASopathy with phenotype determined
by location, either due to distinct
epidermal progenitor types or site-
specific mesenchymal interactions. We
hypothesize that in contrast to strongly
activating RAS mutations found in NS,
which drive hair follicle progenitors
toward sebocyte differentiation, the
more weakly activating mutation found
in WHN permits an intermediate
phenotype with abnormal curly hair
growth but without sebaceous hyper-
plasia.
Parental permission and child assent
was obtained in writing for each of our
cases and our study was approved by
the Yale Human Investigational Com-
mittee and complies with the Declara-
tion of Helsinki Principles.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Lynn Boyden and Young Lim for
critical review of the manuscript, and Jing Zhou,
Young Lim, Li Tian, Carol Nelson-Williams,
Gerald Goh, and Samir Zaidi for technical assis-
tance. This work was supported by a Doris Duke
Charitable Foundation Clinical Scientist Devel-
opment Award to KAC, and by the Yale Center for
Mendelian Genomics (NIH U54 HG006504). JLL
is a recipient of a Clinical Research Mentorship
Award from the Doris Duke Charitable Founda-
tion and is supported by the Medical Scientist
Training Program (NIH NIGMS GM007205) at
Yale University. BGC is supported by a fellow-
ship from the National Institutes of Health (NIH
NIAMS T32AR007016) and by the Dermatology
Foundation.
Jonathan L. Levinsohn1, Joyce Teng2,3,
Brittany G. Craiglow1, Erin C. Loring4,
T. Andrew Burrow5,
Shrikant S. Mane4,6, John D. Overton4,6,
Richard P. Lifton4,6,7,
Jennifer M. McNiff1,8, Anne W. Lucky9
and Keith A. Choate1,8
1Department of Dermatology, Yale University
School of Medicine, New Haven, Connecticut,
USA; 2Department of Dermatology, Stanford
University School of Medicine, Stanford,
California, USA; 3Department of Pediatrics,
Stanford University School of Medicine,
Stanford, California, USA; 4Department of
Genetics, Yale University School of Medicine,
New Haven, Connecticut, USA; 5Division of
Human Genetics, Department of Pediatrics,
Cincinnati Children’s Hospital Medical Center,
Cincinnati, Ohio, USA; 6Yale Center for
Mendelian Genomics, New Haven,
Sample Position (hg19) Gene
Base
change
Protein
effect
# Reads–tissue # Reads–blood
P-valueRef. Non-ref. Ref. Non-ref.
WHN100
WHN101
WHN100 blood
A G G A G/S G A G G A G/S G A G/S GA G G
HRAS, c.G34A, p.Gly12Ser HRAS, c.G34A, p.Gly12Ser HRAS, c.G34A, p.Gly12Ser
WHN100 nevus WHN101 blood WHN101 nevus WHN101 straight WHN101 curly
Chr11: 534,289
Chr11: 534,289 G12S
G12S 29
65 79
19 85
63 5
0 2.4x10–10
2.3x10–12HRAS
HRAS G>A
G>A
Figure 2. Somatic HRAS p.G12S mutation causes woolly hair nevus (WHN). (a) In WHN100 and WHN101, exome sequencing of affected tissue and blood was
performed. Tissue-specific single-nucleotide variations (SNVs) are annotated by chromosome, position, base change, protein consequence, and numbers of
reference and non-reference reads from affected tissue and genomic (blood) DNA. The P-values denoting the significance of the differences in reference and non-
reference reads in tissue versus blood were calculated using a one-tailed Fisher’s exact test. After filtering (Supplementary methods online), only one SNV surpassed
genome-wide significance (1.7 106), HRAS p.G12S in each case. (b, c) Sanger sequencing of blood and tissue of WHN100 and WHN101 confirmed this HRAS
p.G12S mutation. (c) In WHN100, there is a small mutant allele fraction in blood demonstrated by exome (8% mutant reads) sequencing, but this mutation is
enriched to the expected 50:50 ratio in tissue. (d) Sanger sequencing of HRAS in DNA from plucked straight and curly hair from WHN101 shows that HRAS
p.G12S mutation is specific to curly hair.
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Rothmund–Thomson Syndrome and Glomerulonephritis in
a Homozygous C1q-Deficient Patient Due to a Gly164Ser
C1qC Mutation
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TO THE EDITOR
Rothmund–Thomson syndrome (RTS;
MIM#268400) is an autosomal recessive
genodermatosis presenting in infancy
with poikiloderma and heterogeneous
clinical features including short stature,
sparse scalp hair, sparse or absent eye-
lashes and/or eyebrows, juvenile catar-
acts, skeletal abnormalities, radial ray
defects, premature aging, and a predis-
position to osteosarcoma (Larizza et al.,
2010). Approximately 60–65% of RTS
patients carry deleterious mutations in
the helicase gene RECQL4 (RTS-type II),
predominantly exhibiting poikiloderma,
congenital bone defects, and an
increased risk of osteosarcoma. The
remaining cases, characterized by poi-
kiloderma, ectodermal dysplasia, and
juvenile cataracts are negative for the
RECQL4-mutation scan (RTS-type I). At
the present time, the cause of RTS-type I
is unknown.
C1q is the central pattern-recognition
molecule in the classical pathway of the
complement system. Mutations causing
quantitative or functional deficiency of
C1q (MIM#613652) have been associa-
ted with susceptibility to severe infec-
tions, autoimmune disease frequently
including systemic lupus erythematosus
or overlapping clinical entities, and
glomerulonephritis (Botto et al., 1998;
Roumenina et al., 2011; Schejbel et al.,
2011).
Here we report novel and follow-up
data on the case of a 40-year-old man
belonging to an already published Span-
ish family (Leyva-Cobia´n et al., 1981) in
which three siblings were homozygous
C1q deficient and presented with renal
abnormalities and diffuse glomerular
deposits of IgM and C3 compatible
with mesangial proliferative glomerulo-
nephritis. Before the age of 12 years,
the two boys and a girl also developed
oculocutaneus manifestations, poikilo-
derma, and bilateral cataracts, charac-
teristics compatible with RTS. Both
parents and three additional siblings
exhibited partial C1q deficiency and
remained healthy with no sign of RTS
affectation.
Studies have been conducted in the
only survivor from the pedigree origin-
ally published by Leyva-Cobia´n et al.
(1981) that provide new data on this
unusual case. Clinical features in the
patient at diagnosis included macular
erythema, erosive skin lesions on the
face and finger tips, and bilateral
capsular posterior cataracts. At present,
he has not developed osteosarcoma or
other malignancies.Accepted article preview online 24 October 2013; published online 21 November 2013
Abbreviations: RECQL4, RecQ protein-like 4; RTS, Rothmund–Thomson syndrome
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